Literature DB >> 1712132

Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.

N H Sigal1, C S Lin, J J Siekierka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1712132

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A.

Authors:  Jonathan G Bilmen; Laura L Wootton; Francesco Michelangeli
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 2.  Immunobiology and immunopharmacology of organ allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

3.  Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.

Authors:  S el Rouby; Y Shi; G H Reem
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Inhibition by rapamycin of leukocyte migration and bronchial hyperreactivity induced by injection of Sephadex beads to guinea-pigs.

Authors:  J Nogueira de Francischi; D M Conroy; K Maghni; P Sirois
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 5.  Phosphoinositide 3-kinase signaling in the vertebrate retina.

Authors:  Raju V S Rajala
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 6.  New immunosuppressive agents for pediatric transplantation.

Authors:  M Ferraresso; B D Kahan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures.

Authors:  S M McHugh; I R Rifkin; J Deighton; A B Wilson; P J Lachmann; C M Lockwood; P W Ewan
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

8.  Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.

Authors:  Dirk R J Kuypers; Kathleen Claes; Pieter Evenepoel; Bart Maes; Willy Coosemans; Jacques Pirenne; Yves Vanrenterghem
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response--an in vivo model of Th2-like activity.

Authors:  R V Bundick; R I Craggs; E Holness
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

10.  Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients.

Authors:  P Dalal; G Shah; D Chhabra; Lorenzo Gallon
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.